|
1
|
World Health Organization (WHO:
Coronavirus Disease (COVID-19) Pandemic. WHO, Genova, 2021.
https://www.who.int/emergencies/diseases/novel-coronavirus-2019?gclid=Cj0KCQiAhs79BRD0ARIsAC6XpaXhxHeN64r7-j5rvv0ZDtNGxNkA0e2
EWCAUr8QWWj-qi_PPrXOljroaAjXBEALw_wcB. Accessed 30, January
2023.
|
|
2
|
Grasselli G, Greco M, Zanella A, Albano G,
Antonelli M, Bellani G, Bonanomi E, Cabrini L, Carlesso E, Castelli
G, et al: Risk factors associated with mortality among patients
with COVID-19 in intensive care units in Lombardy, Italy. JAMA
Intern Med. 180:1345–1355. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z,
Xiang J, Wang Y, Song B, Gu X, et al: Clinical course and risk
factors for mortality of adult inpatients with COVID-19 in Wuhan,
China: A retrospective cohort study. Lancet. 395:1054–1062.
2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Henry BM, de Oliveira MHS, Benoit S,
Plebani M and Lippi G: Hematologic, biochemical and immune
biomarker abnormalities associated with severe illness and
mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.
Clin Chem Lab Med. 58:1021–1028. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Skevaki C, Fragkou PC, Cheng C, Xie M and
Renz H: Laboratory characteristics of patients infected with the
novel SARS-CoV-2 virus. J Infect. 81:205–212. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bell R, Zini G, d'Onofrio G, Rogers HJ,
Lee YS and Frater JL: The hematology laboratory's response to the
COVID-19 pandemic: A scoping review. Int J Lab Hematol. 43:148–159.
2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ciaccio M and Agnello L: Biochemical
biomarkers alterations in Coronavirus Disease 2019 (COVID-19).
Diagnosis (Berl). 7:365–372. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lippi G and Plebani M: The critical role
of laboratory medicine during coronavirus disease 2019 (COVID-19)
and other viral outbreaks. Clin Chem Lab Med. 58:1063–1069.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lippi G and Plebani M: Laboratory
abnormalities in patients with COVID-2019 infection. Clin Chem Lab
Med. 58:1131–1134. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lim AYH, Goh JL, Chua MCW, Heng BH,
Abisheganaden JA and George PP: Temporal changes of haematological
and radiological findings of the COVID-19 infection-a review of
literature. BMC Pulm Med. 21(37)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Parente J: Diagnostics for White Blood
Cell Abnormalities. Physician Assistant Clinics. 4:625–635.
2019.
|
|
12
|
Yamada T, Wakabayashi M, Yamaji T, Chopra
N, Mikami T, Miyashita H and Miyashita S: Value of leukocytosis and
elevated C-reactive protein in predicting severe coronavirus 2019
(COVID-19): A systematic review and meta-analysis. Clin Chim Acta.
509:235–243. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Elshazli RM, Toraih EA, Elgaml A,
El-Mowafy M, El-Mesery M, Amin MN, Hussein MH, Killackey MT, Fawzy
MS and Kandil E: Diagnostic and prognostic value of hematological
and immunological markers in COVID-19 infection: A meta-analysis of
6320 patients. PLoS One. 15(e0238160)2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhao X, Zhou L, Kou Y and Kou J: Activated
neutrophils in the initiation and progression of COVID-19:
Hyperinflammation and immunothrombosis in COVID-19. Am J Transl
Res. 14:1454–1468. 2022.PubMed/NCBI
|
|
15
|
Banno A, Hifumi T, Okamoto H, Masaki M,
Seki K, Isokawa S, Otani N, Hayashi K and Ishimatsu S: Clinical
characteristics and outcomes of critically ill COVID-19 patients in
Tokyo: A single-center observational study from the first wave. BMC
Infect Dis. 21(163)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Aladağ N and Atabey RD: The role of
concomitant cardiovascular diseases and cardiac biomarkers for
predicting mortality in critical COVID-19 patients. Acta
Cardiologica. 76:132–139. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zheng Y, Sun LJ, Xu M, Pan J, Zhang YT,
Fang XL, Fang Q and Cai HL: Clinical characteristics of 34 COVID-19
patients admitted to intensive care unit in Hangzhou, China. J
Zhejiang Univ Sci B. 21:378–387. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J,
Wang B, Xiang H, Cheng Z, Xiong Y, et al: Clinical characteristics
of 138 hospitalized patients with 2019 novel Coronavirus-infected
pneumonia in Wuhan, China. JAMA. 323:1061–1069. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chen R, Sang L, Jiang M, Yang Z, Jia N, Fu
W, Xie J, Guan W, Liang W, Ni Z, et al: Longitudinal hematologic
and immunologic variations associated with the progression of
COVID-19 patients in China. J Allergy Clin Immunol. 146:89–100.
2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wendel-Garcia PD, Fumeaux T, Guerci P,
Heuberger DM, Montomoli J, Roche-Campo F, Schuepbacha RT and
Hiltyet MP: RISC-19-ICU Investigators. Prognostic factors
associated with mortality risk and disease progression in 639
critically ill patients with COVID-19 in Europe: Initial report of
the international RISC-19-ICU prospective observational cohort.
EClinicalMedicine. 25(100449)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zanella A, Florio G, Antonelli M, Bellani
G, Berselli A, Bove T, Cabrini L, Carlesso E, Castelli GP, Cecconi
M, et al: Time course of risk factors associated with mortality of
1260 critically ill patients with COVID-19 admitted to 24 Italian
intensive care units. Intensive Care Med. 47:995–1008.
2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chen A, Zhao Z, Hou W, Singer AJ, Li H and
Duong TQ: Time-to-death longitudinal characterization of clinical
variables and longitudinal prediction of mortality in COVID-19
patients: A two-center study. Front Med (Lausanne).
8(661940)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Xie J, Wu W, Li S, Hu Y, Hu M, Li J, Yang
Y, Huang T, Zhenget K, Wang Y, et al: Clinical characteristics and
outcomes of critically ill patients with novel coronavirus
infectious disease (COVID-19) in China: A retrospective multicenter
study. Intensive Care Med. 46:1863–1872. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Montrucchio G, Sales G, Rumbolo F,
Palmesino F, Fanelli V, Urbino R, Filippini C, Mengozzi G and
Brazzi L: Effectiveness of mid-regional pro-adrenomedullin
(MR-proADM) as prognostic marker in COVID-19 critically ill
patients: An observational prospective study. PLoS One.
16(e0246771)2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhou S, Yang Y, Zhang X, Li Z, Liu X, Hu
C, Chen C, Wang D and Peng Z: Clinical course of 195 critically ill
COVID-19 patients: A retrospective multicenter study. Shock.
54:644–651. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ouyang SM, Zhu HQ, Xie YN, Zou ZS, Zuo HM,
Rao YW, Liu XY, Zhong B and Chen X: Temporal changes in laboratory
markers of survivors and non-survivors of adult inpatients with
COVID-19. BMC Infect Dis. 20(952)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bolondi G, Russo E, Gamberini E, Circell
A, Meca MCC, Brogi E, Viola L, Bissoni L, Polett V and Agnoletti V:
Iron metabolism and lymphocyte characterisation during Covid-19
infection in ICU patients: An observational cohort study. World J
Emerg Surg. 15(41)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Liu X, Shen Y, Wang H, Ge Q, Fei A and Pan
S: Prognostic significance of neutrophil-to-lymphocyte ratio in
patients with sepsis: A prospective observational study. Mediators
Inflamm. 2016(8191254)2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zhang B, Zhou X, Zhu C, Song Y, Feng F,
Qiu Y, Feng J, Jia Q, Song Q, Zhu B and Wang J: Immune phenotyping
based on the neutrophil-to-lymphocyte ratio and IgG level predicts
disease severity and outcome for patients with COVID-19. Front Mol
Biosci. 7(157)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Garrafa E, Vezzoli M, Ravanelli M, Farina
D, Borghesi A, Calza S and Maroldi R: Early prediction of
in-hospital death of COVID-19 patients: A machine-learning model
based on age, blood analyses, and chest x-ray score. Elife.
10(e70640)2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Liu J, Li SM, Liu J, Liang B, Wang X, Wang
H, Li W, Tong O, Yi J, Zhao L, et al: Longitudinal characteristics
of lymphocyte responses and cytokine profiles in the peripheral
blood of SARS-CoV-2 infected patients. EBiomedicine.
55(102763)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li
C, Zhang M, Tan J, Xu Y, Song R, et al: Neutrophil-to-lymphocyte
ratio predicts severe illness patients with 2019 novel coronavirus
in the early stage. J Transl Med. 18(206)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
King AH, Mehkri O, Rajendram P, Wang X,
Vachharajani V and Duggal A: A high neutrophil-lymphocyte ratio is
associated with increased morbidity and mortality in patients with
Coronavirus disease 2019. Crit Care Explor. 3(e0444)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Sarkar S, Khanna P and Singh AK: The
impact of neutrophil-lymphocyte count ratio in COVID-19: A
systematic review and meta-analysis. J Intensive Care Med.
37:857–869. 2022.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Liu Y, Du X, Chen J, Jin Y, Peng L, Wang
HHX, Luo M, Chen L and Zhao Y: Neutrophil-to-lymphocyte ratio as an
independent risk factor for mortality in hospitalized patients with
COVID-19. J Infection. 81:e6–e12. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ye W, Chen G, Li X, Lan X, Ji C, Hou M,
Zhang D, Zeng G, Wang Y, Xu C, et al: Dynamic changes of D-dimer
and neutrophil-lymphocyte count ratio as prognostic biomarkers in
COVID-19. Respir Res. 21(169)2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Ma A, Cheng J, Yang J, Dong M, Liao X and
Kang Y: Neutrophil-to-lymphocyte ratio as a predictive biomarker
for moderate-severe ARDS in severe COVID-19 patients. Crit Care.
24(288)2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Jiang SQ, Huang QF, Xie WM, Lv C and Quan
XQ: The association between severe COVID-19 and low platelet count:
evidence from 31 observational studies involving 7613 participants.
Br J Haematol. 190:e29–e33. 2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Barrett TJ, Bilaloglu S, Cornwell M,
Burgess HM, Virginio VM, Drenkova K, Ibrahim H, Yuriditsky E,
Aphinyanaphongs Y, Lifshitz M, et al: Platelets contribute to
disease severity in COVID-19. J Thromb Haemost. 19:3139–3153.
2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Jiang X, Zhang W, Ma X and Cheng X: Risk
of hospital mortality in critically ill patients with transient and
persistent thrombocytopenia: A retrospective study. Shock.
58:471–475. 2022.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Liao D, Zhou F, Luo L, Xu M, Wang H, Xia
J, Gao Y, Cai L, Wang Z, Yin P, et al: Haematological
characteristics and risk factors in the classification and
prognosis evaluation of COVID-19: A retrospective cohort study.
Lancet Haematol. 7:e671–e678. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Corrêa TD, Cordioli RL, Campos Guerra JC,
Caldin da Silva B, dos Reis Rodrigues R, de Souza GM, Midega TD,
Campos NS, Carneiro BV, Campos FND, et al: Coagulation profile of
COVID-19 patients admitted to the ICU: An exploratory study. PLoS
One. 15(e0243604)2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
British Thoracic Society: BTS Guidance on
Venous Thromboembolic Disease in patients with COVID-19. Updated
August 2021 - Recently published data and changes to
recommendations in red. https://www.brit-thoracic.org.uk/quality-improvement/covid-19/covid-19-information-for-the-respiratory-community/#bts-guidance-on-venous-thromboembolic-disease-in-patients-with-covid-19.
|
|
44
|
Spadaro S, Fogagnolo A, Campo G, Zucchetti
O, Verri M, Ottaviani I, Tunstall T, Grasso S, Scaramuzzo V,
Murgolo F, et al: Markers of endothelial and epithelial pulmonary
injury in mechanically ventilated COVID-19 ICU patients. Crit Care.
25(74)2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Pavoni V, Gianesello L, Pazzi M, Stera C,
Meconi T and Fritzieri FC: Evaluation of coagulation function by
rotation thromboelastometry in critically ill patients with severe
COVID-19 pneumonia. J Thromb Thrombolysis. 50:281–286.
2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Valerio L, Ferrazzi P, Sacco C, Ruf W,
Kucher N, Konstantinides SV, Barco S and Lodigiani C: Humanitas
COVID-19 Task Force. Course of d-dimer and C-reactive protein
levels in survivors and nonsurvivors with COVID-19 pneumonia: A
retrospective analysis of 577 patients. Thromb Haemost. 121:98–101.
2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Dujardin RWG, Hilderink BN, Haksteen WE,
Middeldorp S, Vlaara APJ, Thachil J, Müller MCA and Juffermans NP:
Biomarkers for the prediction of venous thromboembolism in
critically ill COVID-19 patients. Thromb Res. 196:308–312.
2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Tang N, Li D, Wang X and Sun Z: Abnormal
coagulation parameters are associated with poor prognosis in
patients with novel coronavirus pneumonia. J Thromb Haemost.
18:844–847. 2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Juneja GK, Castelo M, Yeh CH, Cerroni SE,
Hansen BE, Chessum JE, Abraham J, | Cani E, Dwivedi DJ, Fraser DD,
et al: Biomarkers of coagulation, endothelial function, and
fibrinolysis in critically ill patients with COVID-19: A
single-center prospective longitudinal study. J Thromb Haemost.
19:1546–1557. 2021.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Davalos D and Akassoglou K: Fibrinogen as
a key regulator of inflammation in disease. Semin Immunopathol.
34:43–62. 2012.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Sharifpour M, Rangaraju S, Liu M, Alabyad
D, Nahab FB, Creel-Bulos CM and Jabaley CS: Emory COVID-19 Quality
& Clinical Research Collaborative. C-reactive protein as a
prognostic indicator in hospitalized patients with COVID-19. PLoS
One. 15(e0242400)2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Luo X, Zhou W, Yan X, Guo T, Wang B, Xia
H, Ye L, Xiong J, Jiang Z, Liu Y, et al: Prognostic value of
C-reactive protein in patients with Coronavirus 2019. Clin Infect
Dis. 71:2174–2179. 2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, Li
B, Song X and Zhou X: Prognostic value of interleukin-6, C-reactive
protein, and procalcitonin in patients with COVID-19. J Clin Virol.
127(104370)2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Oskarsdottir T, Sigurdsson MI, Palsson R
and Eythorsson E: Longitudinal changes in inflammatory biomarkers
among patients with COVID-19: A nationwide study in Iceland. Acta
Anaesthesiol Scand. 66:969–977. 2022.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Van Oers JAH, Kluiters Y, Bons JAP, de
Jongh M, Pouwels S, Ramnarain D, de Lange DW, de Grooth HJ and
Girbes ARJ: Endothelium-associated biomarkers mid-regional
proadrenomedullin and C-terminal proendothelin-1 have a good
ability to predict 28-day mortality in critically ill patients with
SARS-CoV-2 pneumonia: A prospective cohort study. J Crit Care.
66:173–180. 2021.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Wendel-Garcia PD, Moser A, Jeitziner MM,
Aguirre-Bermeo H, Arias-Sanchez P, Apolo J, Roche-Campo F,
Franch-Llasat D, Kleger GR, Schrag C, et al: Dynamics of disease
characteristics and clinical management of critically ill COVID-19
patients over the time course of the pandemic: An analysis of the
prospective, international, multicentre RISC-19-ICU registry. Crit
Care. 26(199)2022.PubMed/NCBI View Article : Google Scholar
|
|
57
|
RECOVERY Collaborative Group. Horby P, Lim
WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N,
Brightling C, Ustianowski A, et al: Dexamethasone in hospitalized
patients with COVID-19. N Engl J Med. 384:693–704. 2021.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Chalmers JD, Crichton ML, Goeminne PC, Cao
B, Humbert M, Shteinberg M, Antoniou KM, Ulrik CS, Parks H, Wang C,
et al: Management of hospitalised adults with coronavirus disease
2019 (COVID-19): A European Respiratory Society living guideline.
Eur Resp J. 57(2100048)2021.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Zacharias H, Mungara R, Wilson AP, Singer
M and Arulkumaran N: The utility of CRP with the use of
dexamethasone and Tocilizumab in critically ill patients with
COVID-19. J Crit Care. 70(154053)2022.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Fleck A, Raines G, Hawker F, Trotter J,
Wallace PI, Lendingham IM and Calman KC: Increased vascular
permeability: A major cause of hypoalbuminaemia in disease and
injury. Lancet. 1:781–784. 1985.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Soeters PB, Wolfe RR and Shenkin A:
Hypoalbuminemia: Pathogenesis and clinical significance. J Parenter
Enteral Nutr. 43:181–193. 2019.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Siddiqui SS, Chakraborty N, Muzaffar SN
and Gurjar M: Albumin kinetics in sepsis and COVID-19. Crit Care
Explor. 4(e0651)2022.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Viana-Lamas MC, Arroyo-Espliguero R,
Silva-Obregón JA, Uribe-Heredia G, Núñez-Gil I, García-Magallón B,
Torán-Martínez CG, Castillo-Sandoval A, Díaz-Caraballo E,
Rodríguez-Guinea I, et al: Hypoalbuminemia on admission in COVID-19
infection: An early predictor of mortality and adverse events. A
retrospective observational study. Med Clin (Engl Ed). 156:428–436.
2021.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Chen T, Wu D, Chen H, Yan W, Yang D, Chen
G, Ma K, Xu D, Yu H, Wang H, et al: Clinical characteristics of 113
deceased patients with coronavirus disease. 2019, retrospective
study. BMJ. 368(m1091)2020.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Chen G, Wu D, Guo W, Cao Y, Huang D, Wang
H, Wang T, Zhang X, Chen H, Yu H, et al: Clinical and immunological
features of severe and moderate coronavirus disease 2019. J Clin
Invest. 130:2620–2629. 2020.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Su C, Hoffman KL, Xu Z, Sanchez E, Siempos
II, Harrington JS, Racanelli AC, Plataki M, Wang F and Schenck EJ:
Evaluation of albumin kinetics in critically Ill patients with
coronavirus disease 2019 compared to those with sepsis-induced
acute respiratory distress syndrome. Crit Care Explor.
3(e0589)2021.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Venet F, Davin F, Guiqnant C, Larue A,
Cazalis MA, Darbon R, Allombert C, Mougin B, Malcus C,
Poitevin-Later F, et al: Early assessment of leukocyte alterations
at diagnosis of septic shock. Shock. 34:358–363. 2010.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Monserrat J, de Pablo R, Reyes E, Diaz D,
Barcenilla H, Zapata MR, De la Hera A, Prieto A and Alvarez-Mon M:
Clinical relevance of the severe abnormalities of the T cell
compartment in septic shock patients. Crit Care.
13(R26)2009.PubMed/NCBI View
Article : Google Scholar
|
|
69
|
Liu B, Du H, Zhang J, Jiang J, Zhang X, He
F and Niu B: Developing a new sepsis screening tool based on
lymphocyte count, international normalized ratio and procalcitonin
(LIP score) Sci. Rep. 12(20002)2022.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Karakike E, Giamarellos-Bourboulis EJ,
Kyprianou M, Fleischmann-Struzek C, Pletz MW, Netea MG, Reinhart K
and Kyriazopoulou E: Coronavirus disease 2019 as cause of viral
sepsis: A systematic review and meta-analysis. Crit. Care Med.
49:2042–2057. 2021.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Soriano MC, Vaquero C, Ortiz-Fernandez A,
Caballero A, Blandino-Ortiz A and de*Pablo R: Low incidence of
co-infection, but high incidence of ICU-acquired infections in
critically ill patients with COVID-19. J Infect. 82:e20–e21.
2021.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Kokkoris S, Papachatzakis I, Gavrielatou
E, Ntaidou T, Ischaki E, Malachias S, Vrettou C, Nichlos C, Kanavou
A, Zervakis D, et al: ICU-acquired bloodstream infections in
critically ill patients with COVID-19. J Hosp Infect. 107:95–97.
2021.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Routsi C, Meletiadis J, Charitidou E,
Gkoufa A, Kokkoris S, Karageorgiou S, Giannopoulos C, Koulenti D,
Andrikogiannopoulos P, Perivolioti E, et al: Epidemiology of
Candidemia and Fluconazole Resistance in an ICU before and during
the COVID-19 Pandemic Era. Antibiotics (Basel).
11(771)2022.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Bhimraj A, Morgan RL, Shumaker AH, Baden
L, Cheng VCC, Edwards KM, Gallagher JC, Gandhi RT, Muller WJ,
Nakamura MM, et al: Infectious Diseases Society of America
Guidelines on the Treatment and Management of Patients with
COVID-19. Clin Infect Dis: Sep 5, 2022 (Epub ahead of print).
|
|
75
|
Lyons PG, Micek ST, Hampton N and Kollef
M: Sepsis-associated coagulopathy severity predicts hospital
mortality. Crit Care Med. 46:736–742. 2018.PubMed/NCBI View Article : Google Scholar
|
